PHIL (PHIL) Stock Price & Analysis
PHIL (PHIL) rose 0.00% to USD 0 as of June 10, 2026 at 04:01 UTC, according to Nexqual real-time market data.
PHIL last closed at USD 0; the session ranged USD 0–0 on volume of 997,000 shares. Market capitalization is $4.69M, with a 52-week range of USD 0–0 (PNK). Source: Nexqual, June 10, 2026 at 04:01 UTC.
Key Statistics (as of June 10, 2026 at 04:01 UTC)
| Price | USD 0 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0 |
| Open | USD 0 |
| Day Range | USD 0 – 0 |
| 52-Week Range | USD 0 – 0 |
| Volume | 997,000 shares |
| Market Cap | $4.69M |
| Exchange | PNK |
Technical Analysis (PHIL)
Nexqual's technical model rates PHIL "STRONG SELL" based on 0 bullish and 5 bearish signals across 124 daily candles, as of June 10, 2026 at 04:01 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 100 (overbought) |
| vs SMA50 | Below (USD 0) |
| MACD | 0 (negative) |
Analyst Ratings (PHIL)
Wall Street analysts rate PHIL "None", per Nexqual as of June 10, 2026 at 04:01 UTC.
| Consensus Rating | None |
|---|
Earnings (PHIL)
Source: Nexqual, June 10, 2026 at 04:01 UTC.
Financials & Fundamentals (PHIL)
| Total Revenue | $0 |
|---|---|
| Gross Margin | +0.00% |
| Operating Margin | +0.00% |
| Profit Margin | +0.00% |
| Current Ratio | 0 |
| Total Cash | $77 |
| Total Debt | $6.39M |
| Free Cash Flow | $-413,666 |
Source: Nexqual, June 10, 2026 at 04:01 UTC.
Financial Health Score (PHIL)
Nexqual rates PHIL's overall financial health "Weak" across five dimensions, as of June 10, 2026 at 04:01 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Weak — Pre-revenue or very early stage |
| Balance Sheet | Mixed — $77 cash vs $6M debt |
| Cash Flow | Weak — FCF negative: -$414K, burning cash |
| Efficiency | Mixed — No data |
Ownership (PHIL)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +0.00% |
| Shares Outstanding | 46.87B |
| Float | 46.39B |
Source: Nexqual, June 10, 2026 at 04:01 UTC.
Leadership (PHIL)
PHIL is led by Henry D. Fahman (age 70), Chairman, CEO, President & Acting CFO, per Nexqual as of June 10, 2026 at 04:01 UTC.
| Chairman, CEO, President & Acting CFO | Henry D. Fahman (age 70) |
|---|---|
| Managing Director of Philux Capital Advisors Inc. | Gene Michael Bennett (age 77) |
| President of PHIVITAE Healthcare, Inc. & MD of PHI Vietnam Investment & Development Ltd. | Venkateswar Rao Gopisetti |
| Managing Director of Philux Capital Advisors Inc | Daniel Dubell |
| Managing Director of Philux Capital Advisors Inc. | Dang Le Nguyen |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| HPIL | HPIL HLDG | USD 0 | ▲ 0% |
| GTLL | Global Technologies, Ltd. | USD 0 | ▲ 0% |
| WDLF | Decentral Life, Inc. | USD 0 | ▲ 0% |
| VPER | Viper Networks, Inc. | USD 0 | ▼ 33.33% |
| TGGI | Trans Global Group, Inc. | USD 0 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 04:01 UTC. This page is informational and not investment advice.